| Logo | Name | Σ |
|---|---|---|
 | CMS Francis Lefebvre Avocats Notre cabinet d’avocats dispose d’une grande expertise dans de nombreux secteurs d’activité dans plus de 45 pays. CMS Francis Lefebvre Avocats is one of the leading international corporate law firms. It is ranked 2nd largest law firm in France by revenue. Its deep roots, unique positioning and highly recognised expertise enable it to deliver innovative, high-value-added solutions in Tax, Business, Corporate and Employment law. CMS Francis Lefebvre Avocats is a member of CMS. Founded in 1999, CMS, with more than 74 offices in 42 countries across the world, is the 3rd international law firm. Employing over 4,500 lawyers, CMS has … Sectors: Law Practice | 788 |
 | Gilead Sciences Creating Possible At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine. Our focus goes beyond medicines, and we also strive to remedy health inequities and break down barriers to care. We empower our people to tackle these challenges, and we’re all united in our commitment to help millions of people live healthier lives. Social Media Guidelines: https://www.gilead.com/social-media-guidelines Sectors: Biotechnology Pharmaceutical | 831 |
 | KKR KKR is a global investment firm investing across private markets in every asset class all over the world. KKR is a leading global investment firm that offers alternative asset management as well as capital markets and insurance solutions. KKR aims to generate attractive investment returns by following a patient and disciplined investment approach, employing world-class people, and supporting growth in its portfolio companies and communities. KKR sponsors investment funds that invest in private equity, credit and real assets and has strategic partners that manage hedge funds. KKR’s insurance subsidiaries offer retirement, life and reinsurance products under the management of Global … Sectors: Startup accelerator & VC | 929 |
 | Amgen #WeareBiotech Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s known today. Our investment in research and development has yielded a robust pipeline that builds on our existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. Amgen is one of 30 companies comprising the Dow Jones Industrial Average®, and part of the Nasdaq-100 Index®. In 2024, Amgen … Sectors: Biotechnology | 1653 |